RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+9.33%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$5.05B
AUM Growth
+$5.05B
(+10%)
Cap. Flow
+$474M
Cap. Flow
% of AUM
9.39%
Top 10 Holdings %
Top 10 Hldgs %
27.44%
Holding
165
New
13
Increased
67
Reduced
10
Closed
9
Top Buys
| 1 |
Agilon Health
AGL
|
$284M |
| 2 |
LENZ
LENZ Therapeutics
LENZ
|
$66.1M |
| 3 |
VERV
Verve Therapeutics
VERV
|
$58M |
| 4 |
Lifestance Health
LFST
|
$41.8M |
| 5 |
NeueHealth
NEUE
|
$40.8M |
Top Sells
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$100M |
| 2 |
AstraZeneca
AZN
|
$32.3M |
| 3 |
Inspire Medical Systems
INSP
|
$20.7M |
| 4 |
Atea Pharmaceuticals
AVIR
|
$19.4M |
| 5 |
UnitedHealth
UNH
|
$14M |
Sector Composition
| 1 | Healthcare | 94.39% |
| 2 | Consumer Staples | 1.63% |
| 3 | Industrials | 0.72% |
| 4 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
26
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $58.5M | 1.16% | 625,000 | – | – |
|
|
VERV
27
DELISTED
Verve Therapeutics
VERV
| $58M | 1.15% | +962,826 | New | +$58M |
|
|
EAR
28
DELISTED
Eargo, Inc. Common Stock
EAR
| $57.9M | 1.14% | 1,450,000 +598,329 | +70% | +$23.9M |
|
29
Teleflex
TFX
$5.59B
| $52.2M | 1.03% | 130,000 | – | – |
|
|
MRTX
30
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $51.5M | 1.02% | 319,085 -4,562 | -1% | -$737K |
|
31
Alnylam Pharmaceuticals
ALNY
$58.5B
| $50.9M | 1.01% | 300,000 | – | – |
|
32
Prothena Corp
PRTA
$441M
| $48.8M | 0.97% | 950,091 -206,809 | -18% | -$10.6M |
|
33
Arvinas
ARVN
$568M
| $48.2M | 0.95% | 626,100 +4,300 | +0.7% | +$331K |
|
34
Ultragenyx Pharmaceutical
RARE
$2.89B
| $44.3M | 0.88% | 465,000 +15,000 | +3% | +$1.43M |
|
|
KRTX
35
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $44.1M | 0.87% | 386,618 +17,854 | +5% | +$2.04M |
|
36
Acadia Healthcare
ACHC
$2.12B
| $43.9M | 0.87% | 700,000 | – | – |
|
37
Health Catalyst
HCAT
$239M
| $43.6M | 0.86% | 785,000 | – | – |
|
|
38
Lifestance Health
LFST
$2.13B
| $41.8M | 0.83% | +1,500,000 | New | +$41.8M |
|
|
SWAV
39
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $41.7M | 0.82% | 220,000 | – | – |
|
|
40
NeueHealth
NEUE
$59.2M
| $40.8M | 0.81% | +2,375,000 | New | +$40.8M |
|
41
Penumbra
PEN
$10.6B
| $40.4M | 0.8% | 147,500 | – | – |
|
42
Ardelyx
ARDX
$1.53B
| $39.8M | 0.79% | 5,248,829 +72,268 | +1% | +$548K |
|
|
SGEN
43
DELISTED
Seagen Inc. Common Stock
SGEN
| $39.5M | 0.78% | 250,000 | – | – |
|
44
Biogen
BIIB
$19.4B
| $39.3M | 0.78% | 113,500 | – | – |
|
|
CVET
45
DELISTED
Covetrus, Inc. Common Stock
CVET
| $39.3M | 0.78% | 1,455,000 +55,000 | +4% | +$1.49M |
|
46
Encompass Health
EHC
$12.3B
| $39M | 0.77% | 500,000 | – | – |
|
47
NovoCure
NVCR
$1.38B
| $38.8M | 0.77% | 175,000 | – | – |
|
48
Mersana Therapeutics
MRSN
$36.5M
| $38.6M | 0.76% | 2,845,618 +70,491 | +3% | +$957K |
|
|
ACCD
49
DELISTED
Accolade, Inc. Common Stock
ACCD
| $36.1M | 0.71% | 665,000 +40,000 | +6% | +$2.17M |
|
50
Evolent Health
EVH
$1.12B
| $35.9M | 0.71% | 1,699,043 +254,043 | +18% | +$5.37M |
|